SCHEMBL4448836

SCHEMBL4448836

CCCC(C)[CH]CCC(C)CC

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4653001 0.88 TSHR (0.40) TSHR
SCHEMBL4655191 0.85
SCHEMBL4620039 0.79
SCHEMBL9447360 0.79 TSHR (0.32) TSHR
SCHEMBL2035817 0.78 TSHR (0.35) TSHR
SCHEMBL16649186 0.77 TSHR (0.36) TSHR
SCHEMBL2329160 0.77 ALDH1A1 (0.30)
SCHEMBL7173408 0.75 TSHR (0.38) TSHR
SCHEMBL9577267 0.73 TSHR (0.39) TSHR
SCHEMBL306389 0.73 TSHR (0.40) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117616018-A Herbicidal aryl dihydrofuran carboxylic acid esters 巴斯夫欧洲公司 2024-02-27 CN disclosed
US-20090042724-A1 Fungicidal mixtures based on 2,4-disubstituted n-biphenylpyrazolecarboxamides BASF AKTIENGESELLSCHAFT (DE) 2009-02-12 US disclosed
EP-1636279-A1 POLY AND COPOLY (N -VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS Applera Corporation (US) 2006-03-22 EP disclosed
EP-1506213-A1 AN ANTIMICROBIAL AGENT GRIFFITH UNIVERSITY (AU) 2005-02-16 EP disclosed
WO-2004104054-A1 POLY AND COPOLY (N-VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS APPLERA CORPORATION (US) 2004-12-02 WO disclosed
WO-2003097657-A1 AN ANTIMICROBIAL AGENT GRIFFITH UNIVERSITY (AU) 2003-11-27 WO disclosed
EP-1203038-A4 SHAPE MEMORY POLYURETHANE OR POLYURETHANE-UREA POLYMERS AORTECH BIOMATERIALS PTY LTD (AU) 2002-10-30 EP disclosed
CN-1358200-A Catalyst for bulk polymerization, catalyst for vapor phase polymerization, method of polymerization using these and olefymer obtained with these IDEMITSU PETROCHEMICAL CO (JP) 2002-07-10 CN disclosed
EP-1203038-A1 SHAPE MEMORY POLYURETHANE OR POLYURETHANE-UREA POLYMERS AorTech Biomaterials Pty Ltd (AU) 2002-05-08 EP disclosed
WO-2001007499-A1 SHAPE MEMORY POLYURETHANE OR POLYURETHANE-UREA POLYMERS AORTECH BIOMATERIALS PTY LTD. (AU) 2001-02-01 WO disclosed
EP-0628026-B1 CYANO-OXIME ETHERS, PROCESS FOR PRODUCING THEM, AGENTS CONTAINING THEM AND THEIR USE BASF AG (DE) 1997-01-22 EP disclosed
EP-0649454-A1 BENZENE DERIVATIVES AND LIQUID-CRYSTAL MEDIUM MERCK PATENT GmbH (DE) 1995-04-26 EP disclosed
EP-0628026-A1 CYANO-OXIME ETHERS, PROCESS FOR PRODUCING THEM, AGENTS CONTAINING THEM AND THEIR USE. BASF AG (DE) 1994-12-14 EP disclosed
EP-0469423-B1 Oxalyl-bishydroxamic acid derivatives, their preparation and plant growth regulating agents containing them BASF AG (DE) 1994-06-15 EP disclosed
WO-1993016985-A1 CYANO-OXIME ETHERS, PROCESS FOR PRODUCING THEM, AGENTS CONTAINING THEM AND THEIR USE BASF AKTIENGESELLSCHAFT (DE) 1993-09-02 WO disclosed
EP-0469423-A1 Oxalyl-bishydroxamic acid derivatives, their preparation and plant growth regulating agents containing them BASF Aktiengesellschaft (DE) 1992-02-05 EP disclosed
EP-0150461-B1 SULFUR CONTAINING 6-KETOPROSTAGLANDINES MERCK PATENT GmbH (DE) 1988-03-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042724-A1 Fungicidal mixtures based on 2,4-disubstituted n-biphenylpyrazolecarboxamides CBR3, CBR1, SNU13 TSHR 3564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.